test

Dr. Jeffrey R. Jay, M.D.

@Great Point Partners Llc

Latest period2024 - Q3ReportedManaged Assets$339.762MTotal holdings29
Assets growth rate-34.91%Assets growth rate (2-Q avg)-26.77%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Great Point Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Great Point Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.762M in assets, with a quarterly growth rate of -34.91% and a 2-quarter average growth rate of -26.77%. The portfolio is managed by Dr. Jeffrey R. Jay, M.D., and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ZURAZura Bio Ltd
Recent Activity
Decreased -29.69%
3.9%
$13.251M
3.264M shares@ $4.06 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
3.72%
$12.614M
514,659 shares@ $24.51 avg price
MRUSMerus N V
Recent Activity
Decreased -52.22%
3.68%
$12.49M
250,000 shares@ $49.96 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Increased 25.49%
3.52%
$11.94M
1M shares@ $11.94 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
Decreased -22.72%
3.01%
$10.215M
255,000 shares@ $40.06 avg price
AUTLAutolus Therapeutics Plc
Recent Activity
Decreased -18.29%
3.01%
$10.207M
2.812M shares@ $3.64 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -73.89%
2.84%
$9.637M
758,786 shares@ $12.7 avg price
OPTNOptinose Inc
Recent Activity
Decreased -6.3%
2.54%
$8.617M
12.861M shares@ $0.67 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
Decreased -63.71%
2.22%
$7.53M
275,000 shares@ $27.38 avg price
OTLKOutlook Therapeutics Inc
Recent Activity
Decreased -24%
2.04%
$6.905M
1.293M shares@ $5.35 avg price